| Vol. 15.48 – 5 December, 2023 |
| |
|
|
| Investigators demonstrated that MSC-derived apoptotic vesicles (apoVs) were promising therapeutic agents for bone regeneration. However, clinical translation of MSC-derived apoVs had been hindered due to cell expansion and nuclear substance. [ACS Nano] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Transcriptome profiling combined to bioinformatic analyses disclosed a gene signature commonly regulated by DHX9 and the lysine demethylase KDM2B, with the Hippo pathway regulator YAP1 as a prominent target in Ewing sarcoma. [Oncogene] |
|
|
|
| Scientists compared the composition of the conditioned medium obtained after 24 or 72 hours from untreated and cytokine-treated adipose-derived MSCs. [Biomedicine & Pharmacotherapy] |
|
|
|
| Researchers identified enhancers-mediated gene FOXO3 promoting MSC adipogenic differentiation by activating autophagy. [Biochimica Et Biophysica Acta-Molecular Basis Of Disease] |
|
|
|
| Scientists assessed the impact on MSC expansion, gene expression, and other characteristics when different laboratories expanded MSCs from cultures initiated with bone marrow−MSC aliquots derived from the same donor source material yet with different growth media. [Cytotherapy] |
| |
|
|
| Researchers studied the possible benefits of combining tauroursodeoxycholic acid with bone marrow MSC transplantation using an animal model of spinal cord injury. [Molecular Neurobiology] |
|
|
|
| Wharton’s jelly-MSCs were isolated from umbilical cords, and acellular nerve grafts (ANGs) or WJ-MSCs-loaded ANGs were transplanted in injury animal model. [Scientific Reports] |
|
|
|
| Using qPCR, investigators analyzed metastasis-associated lung adenocarcinoma transcript 1 and miR-142 expression in EPCs and human umbilical cord-MSCs. [Archives Of Gerontology And Geriatrics] |
|
|
|
| Researchers investigated the efficacy of the combined use of adipose-derived MSCs (ADSCs) and thrombospondin 1 (TSP1) in polycystic ovary syndrome mice. [Advanced Biology] |
|
|
|
|
|
| The authors review the mechanisms of immune system modulation by MSCs and the role of these cells in the treatment of systemic lupus erythematosus. [Immunological Investigations] |
|
|
|
|
| Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx™ to develop topical skincare formulations that combine mitochondrial biology with Elevai’s human umbilical MSC-derived exosomes. [Elevai Labs, Inc.] |
|
|
|
|
| January 28 – February 2, 2024 Galveston, Texas, United States |
|
|
|
|
|
| University of Texas Health Science Center at San Antonio – San Antonio, Texas, United States |
|
|
|
| University of Sydney – Camperdown, Australia |
|
|
|
| Institut Pasteur – Paris, France |
|
|
|
| University of California, Los Angeles – Los Angeles, California, United States |
|
|
|
| Applied Stem Cell – Milpitas, California, United States |
|
|
|
|